SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-123158
Filing Date
2020-04-28
Accepted
2020-04-28 16:30:35
Documents
5
Period of Report
2020-06-10
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d893193ddef14a.htm DEF 14A 308161
2 GRAPHIC g893193g03s25.jpg GRAPHIC 148791
3 GRAPHIC g893193g04s25.jpg GRAPHIC 113584
4 GRAPHIC g893193g08c20.jpg GRAPHIC 36896
5 GRAPHIC g893193g45s58.jpg GRAPHIC 27240
  Complete submission text file 0001193125-20-123158.txt   759345
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36183 | Film No.: 20825526
SIC: 2836 Biological Products, (No Diagnostic Substances)